GynCor, Inc.
Proposed Ticker: GYNC 750 North Orleans Street
Exchange: NASDAQ-National Market Chicago, Illinois 60610
Industry: Service (312) 397-8200

All share information is proposed
Type of Shares:Common Shares Filing Date:4/23/96
U.S. Shares Filed:2,220,000 Filing Range:$13.00 - $15.00
Non-U.S. Shares Filed:0 Offering Amount: $31,080,000
Primary Shares:2,000,000 Expenses:$1,400,000
Secondary Shares:220,000 Shs Out After:6,654,509

ManagerTierPhone
Smith Barney Inc.Lead Manager (718) 921-8473
Chicago Corporation, TheCo-manager (312) 855-7600

Audited
Income
Latest
Unaudited
Income
Prior
Unaudited
Income
Balance
Sheet
6/30/95 3/31/96 3/31/95 3/31/96
Revenue:$13.88$5.98$2.60Assets:$13.94
Net Income:-$2.36-$2.27-$1.35Liabilities:$15.91
EPS:-$0.64-$0.52-$0.36Equity:-$1.97

Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year,
unaudited figures are partial year

Business Description
The company provides comprehensive management and clinical support services to integrated networks of physicians specializing in the field of reproductive medicine, primarily subspecialties of obstetrics and gynecology and related areas. The company currently manages integrated networks of 17 reproductive medicine centers and 28 physicians in the Chicago, New York City and Tampa/St. Petersburg metropolitan areas. In addition, the company has entered into agreements or letters of intent to add one Center and five physicians to its networks in the New York City metropolitan area and Florida and to establish an additional network of one Center and two physicians in Syracuse, New York. The company anticipates that each of these pending transactions will close prior to the effective date of this offering. The first Center was opened in 1981 an exclusive faculty affiliation with Mount Sinai Hospital and Medical Center in Chicago. Since September 1990, when independent operations began, the company has grown from one Center and three physicians and scientists with doctoral degrees top 19 Centers and 44 physicians and scientists after giving to the pending transactions in New York and Florida.

Use of Proceeds
The proceeds from the proposed offering will be used to repay debt and for general corporate purposes, including future acquisitions, expansion of operations and working capital.

Last updated: 10/28/96

©1996 IPO Data Systems, Inc. - All rights reserved.